chr11-1841014-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_003282.4(TNNI2):c.277-17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0027 in 1,610,828 control chromosomes in the GnomAD database, including 122 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 72 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 50 hom. )
Consequence
TNNI2
NM_003282.4 intron
NM_003282.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.716
Genes affected
TNNI2 (HGNC:11946): (troponin I2, fast skeletal type) This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-1841014-G-A is Benign according to our data. Variant chr11-1841014-G-A is described in ClinVar as [Benign]. Clinvar id is 259025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-1841014-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0143 (2182/152238) while in subpopulation AFR AF= 0.0498 (2069/41542). AF 95% confidence interval is 0.048. There are 72 homozygotes in gnomad4. There are 1015 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2182 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNNI2 | NM_003282.4 | c.277-17G>A | intron_variant | ENST00000381911.6 | NP_003273.1 | |||
TNNI2 | NM_001145829.2 | c.277-17G>A | intron_variant | NP_001139301.1 | ||||
TNNI2 | NM_001145841.2 | c.277-17G>A | intron_variant | NP_001139313.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNNI2 | ENST00000381911.6 | c.277-17G>A | intron_variant | 2 | NM_003282.4 | ENSP00000371336.1 | ||||
TNNI2 | ENST00000252898.11 | c.277-17G>A | intron_variant | 3 | ENSP00000252898.7 | |||||
TNNI2 | ENST00000381905.3 | c.277-17G>A | intron_variant | 3 | ENSP00000371330.3 | |||||
TNNI2 | ENST00000381906.5 | c.277-17G>A | intron_variant | 3 | ENSP00000371331.1 |
Frequencies
GnomAD3 genomes AF: 0.0143 AC: 2175AN: 152120Hom.: 70 Cov.: 33
GnomAD3 genomes
AF:
AC:
2175
AN:
152120
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00344 AC: 827AN: 240304Hom.: 26 AF XY: 0.00252 AC XY: 332AN XY: 131982
GnomAD3 exomes
AF:
AC:
827
AN:
240304
Hom.:
AF XY:
AC XY:
332
AN XY:
131982
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00149 AC: 2168AN: 1458590Hom.: 50 Cov.: 34 AF XY: 0.00127 AC XY: 919AN XY: 725470
GnomAD4 exome
AF:
AC:
2168
AN:
1458590
Hom.:
Cov.:
34
AF XY:
AC XY:
919
AN XY:
725470
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0143 AC: 2182AN: 152238Hom.: 72 Cov.: 33 AF XY: 0.0136 AC XY: 1015AN XY: 74428
GnomAD4 genome
AF:
AC:
2182
AN:
152238
Hom.:
Cov.:
33
AF XY:
AC XY:
1015
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 28, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Distal arthrogryposis type 2B1 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 22, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at